In the UK, multiple regulatory bodies oversee data-sharing across laboratories. The focus lies on integrating genetic test-based clinical data, aiming to assess various treatments’ impacts. Confidence in data infrastructure for Next-Generation Sequencing (NGS) implementation is relatively high, but collaboration among institutions is crucial for effective NGS data integration.
Efforts are directed towards routinely linking sequenced genomic data with clinical records in cancer centers. Additionally, sharing genomic data occurs nationally and internationally, despite complex regulatory frameworks. Patients actively engage in NGS testing, receiving comprehensive information afterward. Genomic data play a pivotal role in both clinical trials and research, promising advancements in understanding genetic contributions to health and disease.
Download the factsheet below.